Literature DB >> 22521362

The relationship between Bayesian motor unit number estimation and histological measurements of motor neurons in wild-type and SOD1(G93A) mice.

S T Ngo1, F Baumann, P G Ridall, A N Pettitt, R D Henderson, M C Bellingham, P A McCombe.   

Abstract

OBJECTIVE: To assess the relationship between Bayesian MUNE and histological motor neuron counts in wild-type mice and in an animal model of ALS.
METHODS: We performed Bayesian MUNE paired with histological counts of motor neurons in the lumbar spinal cord of wild-type mice and transgenic SOD1(G93A) mice that show progressive weakness over time. We evaluated the number of acetylcholine endplates that were innervated by a presynaptic nerve.
RESULTS: In wild-type mice, the motor unit number in the gastrocnemius muscle estimated by Bayesian MUNE was approximately half the number of motor neurons in the region of the spinal cord that contains the cell bodies of the motor neurons supplying the hindlimb crural flexor muscles. In SOD1(G93A) mice, motor neuron numbers declined over time. This was associated with motor endplate denervation at the end-stage of disease.
CONCLUSION: The number of motor neurons in the spinal cord of wild-type mice is proportional to the number of motor units estimated by Bayesian MUNE. In SOD1(G93A) mice, there is a lower number of estimated motor units compared to the number of spinal cord motor neurons at the end-stage of disease, and this is associated with disruption of the neuromuscular junction. SIGNIFICANCE: Our finding that the Bayesian MUNE method gives estimates of motor unit numbers that are proportional to the numbers of motor neurons in the spinal cord supports the clinical use of Bayesian MUNE in monitoring motor unit loss in ALS patients.
Copyright © 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521362     DOI: 10.1016/j.clinph.2012.01.028

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  15 in total

Review 1.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

2.  Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Tesfaye W Tefera; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-19       Impact factor: 6.200

3.  Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis.

Authors:  Emanuele Rizzuto; Simona Pisu; Antonio Musarò; Zaccaria Del Prete
Journal:  Ann Biomed Eng       Date:  2015-01-29       Impact factor: 3.934

4.  A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis.

Authors:  Lavinia Palamiuc; Anna Schlagowski; Shyuan T Ngo; Aurelia Vernay; Sylvie Dirrig-Grosch; Alexandre Henriques; Anne-Laurence Boutillier; Joffrey Zoll; Andoni Echaniz-Laguna; Jean-Philippe Loeffler; Frédérique René
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

5.  Prognostic role of "prion-like propagation" in SOD1-linked familial ALS: an alternative view.

Authors:  Keizo Sugaya; Imaharu Nakano
Journal:  Front Cell Neurosci       Date:  2014-10-31       Impact factor: 5.505

6.  Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles.

Authors:  W David Arnold; Kajri A Sheth; Christopher G Wier; John T Kissel; Arthur H Burghes; Stephen J Kolb
Journal:  J Vis Exp       Date:  2015-09-25       Impact factor: 1.355

7.  Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis.

Authors:  Matthew J Fogarty; Paul M Klenowski; John D Lee; Joy R Drieberg-Thompson; Selena E Bartlett; Shyuan T Ngo; Massimo A Hilliard; Mark C Bellingham; Peter G Noakes
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

8.  Diaphragm neuromuscular transmission failure in a mouse model of an early-onset neuromotor disorder.

Authors:  Matthew J Fogarty; Joline E Brandenburg; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2020-12-31

9.  Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye W Tefera; Yide Wong; Mallory E Barkl-Luke; Shyuan T Ngo; Nicola K Thomas; Tanya S McDonald; Karin Borges
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

10.  Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mice.

Authors:  Christopher G Wier; Alexander E Crum; Anthony B Reynolds; Chitra C Iyer; Deepti Chugh; Marilly S Palettas; Patrick L Heilman; David M Kline; W David Arnold; Stephen J Kolb
Journal:  Muscle Nerve       Date:  2018-12-21       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.